These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 16704829)

  • 41. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.
    Kibiki GS; Mulder B; Dolmans WM; de Beer JL; Boeree M; Sam N; van Soolingen D; Sola C; van der Zanden AG
    BMC Microbiol; 2007 May; 7():51. PubMed ID: 17540031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia.
    Parwati I; Alisjahbana B; Apriani L; Soetikno RD; Ottenhoff TH; van der Zanden AG; van der Meer J; van Soolingen D; van Crevel R
    J Infect Dis; 2010 Feb; 201(4):553-7. PubMed ID: 20064071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype.
    Toungoussova OS; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    FEMS Immunol Med Microbiol; 2004 Nov; 42(3):281-90. PubMed ID: 15477041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drug-resistance in Mycobacterium tuberculosis in Castilla y León, Spain, 2001-2005: third collaborative study].
    Alberte-Castiñeiras A; Campos-Bueno A; López-Urrutia L; Alvarez-Alonso E; Megías G; Ojeda-Fernández E; López-Medrano R; Iglesias-García J; García-Carbajosa S; Pérez-Pascual P
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):706-9. PubMed ID: 20627375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterizing Mycobacterium tuberculosis isolates from Karachi, Pakistan: drug resistance and genotypes.
    Ayaz A; Hasan Z; Jafri S; Inayat R; Mangi R; Channa AA; Malik FR; Ali A; Rafiq Y; Hasan R
    Int J Infect Dis; 2012 Apr; 16(4):e303-9. PubMed ID: 22365136
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].
    Augustynowicz-Kopeć E; Zwolska Z; Jaworski A; Kostrzewa E; Klatt M; Swiderska A; Drozd I
    Pneumonol Alergol Pol; 2002; 70(3-4):193-202. PubMed ID: 12271966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics of multidrug-resistant Mycobacterium tuberculosis in Taiwan: a population-based study.
    Chang CW; Wu MH; Chuang PC; Jou R
    Infect Genet Evol; 2011 Apr; 11(3):633-9. PubMed ID: 21296686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital.
    Liu CH; Yang N; Wang Q; Hu YL; Li L; Zhang GY; Zhu B
    Respirology; 2011 Aug; 16(6):918-25. PubMed ID: 21564401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].
    Wang JJ; Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1189-93. PubMed ID: 20193593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tuberculosis drug resistance: summary report for 2003.
    Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496
    [No Abstract]   [Full Text] [Related]  

  • 51. Epidemic of tuberculosis in the former Soviet Union: social and biological reasons.
    Toungoussova OS; Bjune G; Caugant DA
    Tuberculosis (Edinb); 2006 Jan; 86(1):1-10. PubMed ID: 16256436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nationwide survey of anti-tuberculosis drug resistance in Mongolia.
    Buyankhishig B; Naranbat N; Mitarai S; Rieder HL
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1201-5, i. PubMed ID: 21943846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tuberculosis in Saudi Arabia: prevalence and antimicrobial resistance.
    Yezli S; Memish ZA
    J Chemother; 2012 Feb; 24(1):1-5. PubMed ID: 22546717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of drug resistance in Mycobacterium tuberculosis.
    Zhang Y; Yew WW
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution of the Beijing family genotypes of Mycobacterium tuberculosis in Taiwan.
    Jou R; Chiang CY; Huang WL
    J Clin Microbiol; 2005 Jan; 43(1):95-100. PubMed ID: 15634956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tuberculosis in Tuscany: epidemiology and drug resistance].
    Tanini T; Lorini C; Santomauro F; Comodo N; Bonaccorsi G
    Ig Sanita Pubbl; 2012; 68(5):645-55. PubMed ID: 23223316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resistance to anti-tuberculosis medications in the Horn of Africa.
    Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The Mycobacterium tuberculosis Beijing genotype worldwide and in the Czech Republic. Review].
    Kubín M
    Epidemiol Mikrobiol Imunol; 2003 Apr; 52(2):84-6. PubMed ID: 12822540
    [No Abstract]   [Full Text] [Related]  

  • 59. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology.
    Tudó G; González J; Obama R; Rodríguez JM; Franco JR; Espasa M; Simarro PR; Escaramís G; Ascaso C; García A; Jiménez de Anta MT
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):15-22. PubMed ID: 14974741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging resistant clone of Mycobacterium tuberculosis in west Asia.
    Mokrousov I
    Lancet Infect Dis; 2016 Dec; 16(12):1326-1327. PubMed ID: 27998587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.